George K Bertsias (G Bertsias, George Bertsias, G K Bertsias)

Publication Activity (10 Years)

Years Active: 2018-2024
Publications (10 Years): 68

Top Topics

Machine Learning

Systemic Lupus Erythematosus

Peripheral Blood

Monoclonal Antibody

Top Venues

Annals of the rheumatic diseases

Lupus science & medicine

Journal of clinical medicine

This page only lists publications with an associated author ORCID identifier.

Publications

Myrto Kostopoulou, Chetan B Mukhtyar, George K Bertsias, Dimitrios T Boumpas, Antonis Fanouriakis
Management of systemic lupus erythematosus: a systematic literature review informing the 2023 update of the EULAR recommendations. Annals of the rheumatic diseases (2024)
George K Bertsias, Anca D Askanase, Andrea Doria, Amit Saxena, Edward M Vital
A path to Glucocorticoid Stewardship: a critical review of clinical recommendations for the treatment of systemic lupus erythematosus. Rheumatology (Oxford, England) 63 (7) (2024)
Sofia Pitsigavdaki, Myrto Nikoloudaki, Panagiotis Garantziotis, Ettore Silvagni, Argyro Repa, Antonio Marangoni, Irini Flouri, Nestor Avgoustidis, Konstantinos Parperis, Antonis Fanouriakis, Marcello Govoni, Prodromos Sidiropoulos, Dimitrios T Boumpas, Alessandra Bortoluzzi, George K Bertsias
Pragmatic targets for moderate/severe SLE and their implications for clinical care and trial design: sustained DORIS or LLDAS for at least 6 months is sufficient while their attainment for at least 24 months ensures high specificity for damage-free progression. Annals of the rheumatic diseases 83 (4) (2024)
Dionysis S Nikolopoulos, Catherine Loukogiannaki, George Sentis, Panagiotis Garantziotis, Theodora Manolakou, Noemin Kapsala, Myrto Nikoloudaki, Antigone Pieta, Sofia Flouda, Ioannis Parodis, George K Bertsias, Antonis Fanouriakis, Anastasia Filia, Dimitrios T Boumpas
Disentangling the riddle of systemic lupus erythematosus with antiphospholipid syndrome: blood transcriptome analysis reveals a less-pronounced IFN-signature and distinct molecular profiles in venous versus arterial events. Annals of the rheumatic diseases (2024)
Sofia Pitsigavdaki, Myrto Nikoloudaki, Panagiotis Garantziotis, Ettore Silvagni, Argyro Repa, Antonio Marangoni, Irini Flouri, Nestor Avgoustidis, Konstantinos Parperis, Antonis Fanouriakis, Marcello Govoni, Prodromos Sidiropoulos, Dimitrios T Boumpas, Alessandra Bortoluzzi, George K Bertsias
Pragmatic targets for moderate/severe SLE and their implications for clinical care and trial design: sustained DORIS or LLDAS for at least 6 months is sufficient while their attainment for at least 24 months ensures high specificity for damage-free progression. Annals of the rheumatic diseases 83 (4) (2024)
George K Bertsias, Anca D Askanase, Andrea Doria, Amit Saxena, Edward M Vital
A path to Glucocorticoid Stewardship: a critical review of clinical recommendations for the treatment of systemic lupus erythematosus. Rheumatology (Oxford, England) 63 (7) (2024)
Antonios Bertsias, Irini D Flouri, Argyro Repa, Nestor Avgoustidis, Eleni Kalogiannaki, Sofia Pitsigavdaki, George K Bertsias, Prodromos Sidiropoulos
Patterns of comorbidities differentially affect long-term functional evolution and disease activity in patients with 'difficult to treat' rheumatoid arthritis. RMD open 10 (1) (2024)
Maria Pappa, Maria Kosmetatou, Antigone Pieta, Myrto Nikoloudaki, Nektarios Marios Liapis, Christina Tsalapaki, Aglaia Chalkia, Evangelia Argyriou, Theodoros Dimitroulas, Myrto Cheila, Georgios Demirtzoglou, Charalampos Papagoras, Andreas Goules, Christina Katsiari, Dimitrios Vassilopoulos, Prodromos Sidiropoulos, Kyriaki A Boki, Petros P Sfikakis, George Liapis, Harikleia Gakiopoulou, Paraskevi Vasileios Voulgari, Dimitrios T Boumpas, George K Bertsias, Maria G G Tektonidou, Antonis Fanouriakis
Attainment of EULAR/ERA-EDTA targets of therapy with current immunosuppressive regimens and adjustments in treatment: a multicentre, real-life observational study. RMD open 10 (3) (2024)
Sofia Pitsigavdaki, Myrto Nikoloudaki, Panagiotis Garantziotis, Ettore Silvagni, Argyro Repa, Antonio Marangoni, Irini Flouri, Nestor Avgoustidis, Konstantinos Parperis, Antonis Fanouriakis, Marcello Govoni, Prodromos Sidiropoulos, Dimitrios T Boumpas, Alessandra Bortoluzzi, George K Bertsias
Pragmatic targets for moderate/severe SLE and their implications for clinical care and trial design: sustained DORIS or LLDAS for at least 6 months is sufficient while their attainment for at least 24 months ensures high specificity for damage-free progression. Annals of the rheumatic diseases 83 (4) (2024)
George K Bertsias, Anca D Askanase, Andrea Doria, Amit Saxena, Edward M Vital
A path to Glucocorticoid Stewardship: a critical review of clinical recommendations for the treatment of systemic lupus erythematosus. Rheumatology (Oxford, England) 63 (7) (2024)
Antonios Bertsias, Irini D Flouri, Argyro Repa, Nestor Avgoustidis, Eleni Kalogiannaki, Sofia Pitsigavdaki, George K Bertsias, Prodromos Sidiropoulos
Patterns of comorbidities differentially affect long-term functional evolution and disease activity in patients with 'difficult to treat' rheumatoid arthritis. RMD open 10 (1) (2024)
Antonis Fanouriakis, George K Bertsias, Dimitrios T Boumpas
Response to: Correspondence on 'EULAR recommendations for the management of systemic lupus erythematosus: 2023 update' by Fanouriakis et al . Annals of the rheumatic diseases (2024)
Sofia Pitsigavdaki, Myrto Nikoloudaki, Panagiotis Garantziotis, Ettore Silvagni, Argyro Repa, Antonio Marangoni, Irini Flouri, Nestor Avgoustidis, Konstantinos Parperis, Antonis Fanouriakis, Marcello Govoni, Prodromos Sidiropoulos, Dimitrios T Boumpas, Alessandra Bortoluzzi, George K Bertsias
Pragmatic targets for moderate/severe SLE and their implications for clinical care and trial design: sustained DORIS or LLDAS for at least 6 months is sufficient while their attainment for at least 24 months ensures high specificity for damage-free progression. Annals of the rheumatic diseases (2024)
Sofia Flouda, Evgenia Emmanouilidou, Anastasios Karamanakos, Dimitra Koumaki, Dimitrios Katsifis-Nezis, Argyro Repa, George K Bertsias, Dimitrios Boumpas, Antonis Fanouriakis
Anifrolumab for systemic lupus erythematosus with multi-refractory skin disease: A case series of 18 patients. Lupus (2024)
Antonios Bertsias, Irini D Flouri, Argyro Repa, Nestor Avgoustidis, Eleni Kalogiannaki, Sofia Pitsigavdaki, George K Bertsias, Prodromos Sidiropoulos
Patterns of comorbidities differentially affect long-term functional evolution and disease activity in patients with 'difficult to treat' rheumatoid arthritis. RMD open 10 (1) (2024)
Antonis Fanouriakis, Myrto Kostopoulou, George K Bertsias, Dimitrios T Boumpas
Response to: Correspondence on 'EULAR recommendations for the management of systemic lupus erythematosus: 2023 update' by Fanouriakis et al . Annals of the rheumatic diseases (2024)
Sofia Pitsigavdaki, Myrto Nikoloudaki, Panagiotis Garantziotis, Ettore Silvagni, Argyro Repa, Antonio Marangoni, Irini Flouri, Nestor Avgoustidis, Konstantinos Parperis, Antonis Fanouriakis, Marcello Govoni, Prodromos Sidiropoulos, Dimitrios T Boumpas, Alessandra Bortoluzzi, George K Bertsias
Pragmatic targets for moderate/severe SLE and their implications for clinical care and trial design: sustained DORIS or LLDAS for at least 6 months is sufficient while their attainment for at least 24 months ensures high specificity for damage-free progression. Annals of the rheumatic diseases 83 (4) (2024)
Dionysis S Nikolopoulos, Catherine Loukogiannaki, George Sentis, Panagiotis Garantziotis, Theodora Manolakou, Noemin Kapsala, Myrto Nikoloudaki, Antigone Pieta, Sofia Flouda, Ioannis Parodis, George K Bertsias, Antonis Fanouriakis, Anastasia Filia, Dimitrios T Boumpas
Disentangling the riddle of systemic lupus erythematosus with antiphospholipid syndrome: blood transcriptome analysis reveals a less-pronounced IFN-signature and distinct molecular profiles in venous versus arterial events. Annals of the rheumatic diseases 83 (9) (2024)
George K Bertsias, Anca D Askanase, Andrea Doria, Amit Saxena, Edward M Vital
A path to Glucocorticoid Stewardship: a critical review of clinical recommendations for the treatment of systemic lupus erythematosus. Rheumatology (Oxford, England) (2024)
Antonios Bertsias, Irini D Flouri, Argyro Repa, Nestor Avgoustidis, Eleni Kalogiannaki, Sofia Pitsigavdaki, George K Bertsias, Prodromos Sidiropoulos
Patterns of comorbidities differentially affect long-term functional evolution and disease activity in patients with 'difficult to treat' rheumatoid arthritis. RMD open 10 (1) (2024)
Sofia Pitsigavdaki, Myrto Nikoloudaki, Panagiotis Garantziotis, Ettore Silvagni, Argyro Repa, Antonio Marangoni, Irini Flouri, Nestor Avgoustidis, Konstantinos Parperis, Antonis Fanouriakis, Marcello Govoni, Prodromos Sidiropoulos, Dimitrios T Boumpas, Alessandra Bortoluzzi, George K Bertsias
Pragmatic targets for moderate/severe SLE and their implications for clinical care and trial design: sustained DORIS or LLDAS for at least 6 months is sufficient while their attainment for at least 24 months ensures high specificity for damage-free progression. Annals of the rheumatic diseases 83 (4) (2024)
Spyridon Katechis, Dionysis S Nikolopoulos, Sofia Flouda, Christina Adamichou, Katerina Chavatza, Noemin Kapsala, Pelagia Katsimbri, George K Bertsias, Dimitrios T Boumpas, Antonis Fanouriakis
Can we predict kidney involvement in patients with systemic lupus erythematosus? A retrospective cohort study with independent validation. Rheumatology (Oxford, England) (2024)
Binod Neupane, Pragya Shukla, Mahmoud Slim, Amber Martin, Michelle A Petri, George K Bertsias, Alfred H J Kim, Antonis Fanouriakis, Roger Abramino Levy, Deven Chauhan, Nick Ballew
Belimumab versus anifrolumab in adults with systemic lupus erythematosus: an indirect comparison of clinical response at 52 weeks. Lupus science & medicine 10 (1) (2023)
Binod Neupane, Pragya Shukla, Mahmoud Slim, Amber Martin, Michelle A Petri, George K Bertsias, Alfred H J Kim, Antonis Fanouriakis, Roger Abramino Levy, Deven Chauhan, Nick Ballew
Belimumab versus anifrolumab in adults with systemic lupus erythematosus: an indirect comparison of clinical response at 52 weeks. Lupus science & medicine 10 (1) (2023)
Antonis Fanouriakis, Myrto Kostopoulou, Jeanette Andersen, Martin Aringer, Laurent Arnaud, Sang-Cheol Bae, John Boletis, Ian N Bruce, Ricard Cervera, Andrea Doria, Thomas Dörner, Richard A Furie, Dafna D Gladman, Frederic A Houssiau, Luís Sousa Inês, David R W Jayne, Marios Kouloumas, László Kovács, Chi Chiu Mok, Eric F Morand, Gabriella Moroni, Marta Mosca, Johanna Mucke, Chetan B Mukhtyar, György Nagy, Sandra Navarra, Ioannis Parodis, José M Pego-Reigosa, Michelle A Petri, Bernardo A Pons-Estel, Matthias Schneider, Josef S Smolen, Elisabet Svenungsson, Yoshiya Tanaka, Maria G G Tektonidou, Y K Onno Teng, Angela Tincani, Edward M Vital, Ronald F Van Vollenhoven, Chris Wincup, George K Bertsias, Dimitrios T Boumpas
EULAR recommendations for the management of systemic lupus erythematosus: 2023 update. Annals of the rheumatic diseases (2023)
Konstantinos Triantafyllias, Leif-Erik Thiele, Anna Mandel, Lorenzo Cavagna, Xenofon Baraliakos, George K Bertsias, Rebecca Hasseli, Pascal Minnich, Andreas Schwarting
Arterial Stiffness as a Surrogate Marker of Cardiovascular Disease and Atherosclerosis in Patients with Vasculitides: A Literature Review. Diagnostics (Basel, Switzerland) 13 (24) (2023)
Panagiota Goutakoli, Garyfalia Papadaki, Argyro Repa, Nestor Avgoustidis, Eleni Kalogiannaki, Irini Flouri, Antonios Bertsias, Jerome Zoidakis, Martina K Samiotaki, George K Bertsias, Maria Semitekolou, Panayotis Verginis, Prodromos Sidiropoulos
A Peripheral Blood Signature of Increased Th1 and Myeloid Cells Combined with Serum Inflammatory Mediators Is Associated with Response to Abatacept in Rheumatoid Arthritis Patients. Cells 12 (24) (2023)
Irini D Flouri, Panagiota Goutakoli, Argyro Repa, Antonios Konstantinos Bertsias, Nestor Avgoustidis, Anastasios Eskitzis, Sofia Pitsigavdaki, Eleni Kalogiannaki, Maria Terizaki, George K Bertsias, Prodromos Sidiropoulos
Distinct long-term disease activity trajectories differentiate early on treatment with etanercept in both rheumatoid arthritis and spondylarthritis patients: a prospective cohort study. Rheumatology international (2023)
Konstantinos Triantafyllias, Leif-Erik Thiele, Anna Mandel, Lorenzo Cavagna, Xenofon Baraliakos, George K Bertsias, Rebecca Hasseli, Pascal Minnich, Andreas Schwarting
Arterial Stiffness as a Surrogate Marker of Cardiovascular Disease and Atherosclerosis in Patients with Vasculitides: A Literature Review. Diagnostics (Basel, Switzerland) 13 (24) (2023)
Binod Neupane, Pragya Shukla, Mahmoud Slim, Amber Martin, Michelle A Petri, George K Bertsias, Alfred H J Kim, Antonis Fanouriakis, Roger Abramino Levy, Deven Chauhan, Nick Ballew
Belimumab versus anifrolumab in adults with systemic lupus erythematosus: an indirect comparison of clinical response at 52 weeks. Lupus science & medicine 10 (1) (2023)
Aggelos Banos, George K Bertsias
Flares in Lupus Nephritis: Risk Factors and Strategies for Their Prevention. Current rheumatology reports (2023)
Panagiota Goutakoli, Garyfalia Papadaki, Argyro Repa, Nestor Avgoustidis, Eleni Kalogiannaki, Irini Flouri, Antonios Bertsias, Jerome Zoidakis, Martina K Samiotaki, George K Bertsias, Maria Semitekolou, Panayotis Verginis, Prodromos Sidiropoulos
A Peripheral Blood Signature of Increased Th1 and Myeloid Cells Combined with Serum Inflammatory Mediators Is Associated with Response to Abatacept in Rheumatoid Arthritis Patients. Cells 12 (24) (2023)
Anastasia Pentari, Nicholas Simos, George Tzagarakis, Antonios Kagialis, George K Bertsias, Eleftherios Kavroulakis, Eirini Gratsia, Prodromos Sidiropoulos, Dimitrios T Boumpas, Efrosini Papadaki
Altered hippocampal connectivity dynamics predicts memory performance in neuropsychiatric lupus: a resting-state fMRI study using cross-recurrence quantification analysis. Lupus science & medicine 10 (2) (2023)
Konstantinos Triantafyllias, Leif-Erik Thiele, Anna Mandel, Lorenzo Cavagna, Xenofon Baraliakos, George K Bertsias, Rebecca Hasseli, Pascal Minnich, Andreas Schwarting
Arterial Stiffness as a Surrogate Marker of Cardiovascular Disease and Atherosclerosis in Patients with Vasculitides: A Literature Review. Diagnostics (Basel, Switzerland) 13 (24) (2023)
Antonis Fanouriakis, George K Bertsias, George Liapis, Smaragdi Marinaki, Aikaterini Papagianni, Maria Stangou, Alexandros Garyfallos, Sophia Lionaki, Maria G G Tektonidou, John N Boletis, Dimitrios T Boumpas
Multidisciplinary approach to lupus nephritis: Clinical pearls, pitfalls, and positioning of newly-approved agents. Lupus (2023)
Binod Neupane, Pragya Shukla, Mahmoud Slim, Amber Martin, Michelle A Petri, George K Bertsias, Alfred H J Kim, Antonis Fanouriakis, Roger Abramino Levy, Deven Chauhan, Nick Ballew
Belimumab versus anifrolumab in adults with systemic lupus erythematosus: an indirect comparison of clinical response at 52 weeks. Lupus science & medicine 10 (1) (2023)
Giacomo Emmi, Alessandra Bettiol, Elena Gelain, Ingeborg M Bajema, Alvise Berti, Stella Burns, Maria Cinta Cid, Jan W Cohen Tervaert, Vincent Cottin, Eugenia Durante, Julia U Holle, Alfred D Mahr, Marcos Martinez Del Pero, Chiara Marvisi, John Mills, Sergey Moiseev, Frank Moosig, Chetan Mukhtyar, Thomas Neumann, Iacopo Olivotto, Carlo Salvarani, Benjamin Seeliger, Renato A Sinico, Camille Taillé, Benjamin Terrier, Nils Venhoff, George K Bertsias, Loïc Guillevin, David R W Jayne, Augusto Vaglio
Evidence-Based Guideline for the diagnosis and management of eosinophilic granulomatosis with polyangiitis. Nature reviews. Rheumatology (2023)
Panagiota Goutakoli, Garyfalia Papadaki, Argyro Repa, Nestor Avgoustidis, Eleni Kalogiannaki, Irini Flouri, Antonios Bertsias, Jerome Zoidakis, Martina K Samiotaki, George K Bertsias, Maria Semitekolou, Panayotis Verginis, Prodromos Sidiropoulos
A Peripheral Blood Signature of Increased Th1 and Myeloid Cells Combined with Serum Inflammatory Mediators Is Associated with Response to Abatacept in Rheumatoid Arthritis Patients. Cells 12 (24) (2023)
Panagiota Goutakoli, Garyfalia Papadaki, Argyro Repa, Nestor Avgoustidis, Eleni Kalogiannaki, Irini Flouri, Antonios Bertsias, Jerome Zoidakis, Martina K Samiotaki, George K Bertsias, Maria Semitekolou, Panayotis Verginis, Prodromos Sidiropoulos
A Peripheral Blood Signature of Increased Th1 and Myeloid Cells Combined with Serum Inflammatory Mediators Is Associated with Response to Abatacept in Rheumatoid Arthritis Patients. Cells 12 (24) (2023)
Evgenia Emmanouilidou, Despoina Kosmara, Efrosini Papadaki, Vasileios Mastorodemos, Pantelis Constantoulakis, Argyro Repa, Georgia Christopoulou, Christina Kalpadakis, Nestor Avgoustidis, Konstantinos Thomas, Dimitrios Boumpas, Prodromos Sidiropoulos, George K Bertsias
Progressive Multifocal Leukoencephalopathy in Systemic Lupus Erythematosus: A Consequence of Patient-Intrinsic or -Extrinsic Factors? Journal of clinical medicine 12 (21) (2023)
Konstantinos Triantafyllias, Leif-Erik Thiele, Lorenzo Cavagna, Xenofon Baraliakos, George K Bertsias, Andreas Schwarting
Arterial Stiffness as a Surrogate Marker of Cardiovascular Disease and Atherosclerosis in Patients with Arthritides and Connective Tissue Diseases: A Literature Review. Diagnostics (Basel, Switzerland) 13 (11) (2023)
Binod Neupane, Pragya Shukla, Mahmoud Slim, Amber Martin, Michelle A Petri, George K Bertsias, Alfred H J Kim, Antonis Fanouriakis, Roger Abramino Levy, Deven Chauhan, Nick Ballew
Belimumab versus anifrolumab in adults with systemic lupus erythematosus: an indirect comparison of clinical response at 52 weeks. Lupus science & medicine 10 (1) (2023)
Despoina Kosmara, Sofia Papanikolaou, Christoforos Nikolaou, George K Bertsias
Extensive Alternative Splicing Patterns in Systemic Lupus Erythematosus Highlight Sexual Differences. Cells 12 (23) (2023)
Panagiota Goutakoli, Garyfalia Papadaki, Argyro Repa, Nestor Avgoustidis, Eleni Kalogiannaki, Irini Flouri, Antonios Bertsias, Jerome Zoidakis, Martina K Samiotaki, George K Bertsias, Maria Semitekolou, Panayotis Verginis, Prodromos Sidiropoulos
A Peripheral Blood Signature of Increased Th1 and Myeloid Cells Combined with Serum Inflammatory Mediators Is Associated with Response to Abatacept in Rheumatoid Arthritis Patients. Cells 12 (24) (2023)
Myrto Nikoloudaki, Argyro Repa, Sofia Pitsigavdaki, Ainour Molla Ismail Sali, Prodromos Sidiropoulos, Christos Lionis, George K Bertsias
Persistence of Depression and Anxiety despite Short-Term Disease Activity Improvement in Patients with Systemic Lupus Erythematosus: A Single-Centre, Prospective Study. Journal of clinical medicine 11 (15) (2022)
Myrto Kostopoulou, Sofia Pitsigavdaki, George K Bertsias
Lupus Nephritis: Improving Treatment Options. Drugs 82 (7) (2022)
Myrto Kostopoulou, Manuel Francisco Ugarte-Gil, Bernardo Pons-Estel, Ronald F van Vollenhoven, George K Bertsias
The association between lupus serology and disease outcomes: A systematic literature review to inform the treat-to-target approach in systemic lupus erythematosus. Lupus 31 (3) (2022)
Myrto Nikoloudaki, Argyro Repa, Sofia Pitsigavdaki, Ainour Molla Ismail Sali, Prodromos Sidiropoulos, Christos Lionis, George K Bertsias
Correction: Nikoloudaki et al. Persistence of Depression and Anxiety despite Short-Term Disease Activity Improvement in Patients with Systemic Lupus Erythematosus: A Single-Centre, Prospective Study. J. Clin. Med. 2022, 11 , 4316. Journal of clinical medicine 12 (1) (2022)
George K Bertsias
Dialogue: High-throughput studies in rheumatology: time for unsupervised clustering? Lupus science & medicine 8 (1) (2022)
Garyfalia Papadaki, Panagiota Goutakoli, Ioanna Tiniakou, Joachim R Grün, Andreas Grützkau, Georgios A Pavlopoulos, Ioannis Iliopoulos, George K Bertsias, Dimitrios Boumpas, Caroline Ospelt, Boris Reizis, Prodromos Sidiropoulos, Panayotis Verginis
IL-6 Signaling Attenuates TNF-α Production by Plasmacytoid Dendritic Cells in Rheumatoid Arthritis. Journal of immunology (Baltimore, Md. : 1950) 209 (10) (2022)
Ourania Gioti, Katerina Chavatza, Myrto Nikoloudaki, Spyridon Katechis, George K Bertsias, Dimitrios T Boumpas, Antonis Fanouriakis
Residual disease activity and treatment intensification in systemic lupus erythematosus: A cross-sectional study to quantify the need for new therapies. Lupus 31 (14) (2022)
Myrto Nikoloudaki, Argyro Repa, Sofia Pitsigavdaki, Ainour Molla Ismail Sali, Prodromos Sidiropoulos, Christos Lionis, George K Bertsias
Correction: Nikoloudaki et al. Persistence of Depression and Anxiety despite Short-Term Disease Activity Improvement in Patients with Systemic Lupus Erythematosus: A Single-Centre, Prospective Study. J. Clin. Med. 2022, 11 , 4316. Journal of clinical medicine 12 (1) (2022)
Myrto Nikoloudaki, Argyro Repa, Sofia Pitsigavdaki, Ainour Molla Ismail Sali, Prodromos Sidiropoulos, Christos Lionis, George K Bertsias
Correction: Nikoloudaki et al. Persistence of Depression and Anxiety despite Short-Term Disease Activity Improvement in Patients with Systemic Lupus Erythematosus: A Single-Centre, Prospective Study. J. Clin. Med. 2022, 11 , 4316. Journal of clinical medicine 12 (1) (2022)
Irini Gergianaki, Panagiotis Garantziotis, Christina Adamichou, Ioannis Saridakis, Georgios Spyrou, Prodromos Sidiropoulos, George K Bertsias
High Comorbidity Burden in Patients with SLE: Data from the Community-Based Lupus Registry of Crete. Journal of clinical medicine 10 (5) (2021)
Emmanouil Papastefanakis, Georgia Dimitraki, Georgia Ktistaki, Antonis Fanouriakis, Penny Karamaouna, Achilles Bardos, Ioannis Kallitsakis, Christina Adamichou, Irini Gergianaki, Argyro Repa, George K Bertsias, Prodromos Sidiropoulos, Evangelos Karademas, Panagiotis Simos
Screening for cognitive impairment in systemic lupus erythematosus: Application of the Montreal Cognitive Assessment (MoCA) in a Greek patient sample. Lupus (2021)
Christina Adamichou, Irini Genitsaridi, Dionysis S Nikolopoulos, Myrto Nikoloudaki, Argyro Repa, Alessandra Bortoluzzi, Antonis Fanouriakis, Prodromos Sidiropoulos, Dimitrios T Boumpas, George K Bertsias
Lupus or not? SLE Risk Probability Index (SLERPI): a simple, clinician-friendly machine learning-based model to assist the diagnosis of systemic lupus erythematosus. Annals of the rheumatic diseases (2021)
Sofia Papanikolaou, George K Bertsias, Christoforos Nikolaou
Extensive Changes in Transcription Dynamics Reflected on Alternative Splicing Events in Systemic Lupus Erythematosus Patients. Genes 12 (8) (2021)
Dionysis S Nikolopoulos, Antonis Fanouriakis, George K Bertsias
Treatment of neuropsychiatric systemic lupus erythematosus: clinical challenges and future perspectives. Expert review of clinical immunology 17 (4) (2021)
Dionysis S Nikolopoulos, Dimitris Kitsos, Matilda Papathanasiou, Maria Chondrogianni, Aikaterini Theodorou, Panagiotis Garantziotis, Antigone Pieta, Triantafyllos Doskas, George K Bertsias, Konstantinos Voumvourakis, Dimitrios T Boumpas, Antonis Fanouriakis
Demyelination with autoimmune features: a distinct clinical entity? Results from a longitudinal cohort. Rheumatology (Oxford, England) 60 (9) (2021)
Antonis Fanouriakis, Nikolaos Tziolos, George K Bertsias, Dimitrios T Boumpas
Update οn the diagnosis and management of systemic lupus erythematosus. Annals of the rheumatic diseases 80 (1) (2020)
Nicholas John Simos, Stavros I Dimitriadis, Eleftherios Kavroulakis, Georgios C Manikis, George K Bertsias, Panagiotis Simos, Thomas G Maris, Efrosini Papadaki
Quantitative Identification of Functional Connectivity Disturbances in Neuropsychiatric Lupus Based on Resting-State fMRI: A Robust Machine Learning Approach. Brain sciences 10 (11) (2020)
Chrysoula Stathopoulou, Dimitra Nikoleri, George K Bertsias
Immunometabolism: an overview and therapeutic prospects in autoimmune diseases. Immunotherapy 11 (9) (2020)
Christina Adamichou, Dionysis Nikolopoulos, Irini Genitsaridi, Alessandra Bortoluzzi, Antonis Fanouriakis, Emmanouil Papastefanakis, Eleni Kalogiannaki, Irini Gergianaki, Prodromos Sidiropoulos, Dimitrios T Boumpas, George K Bertsias
In an early SLE cohort the ACR-1997, SLICC-2012 and EULAR/ACR-2019 criteria classify non-overlapping groups of patients: use of all three criteria ensures optimal capture for clinical studies while their modification earlier classification and treatment. Annals of the rheumatic diseases 79 (2) (2019)
Antonis Fanouriakis, George K Bertsias, Dimitrios T Boumpas
Chloroquine as alternative antimalarial in systemic lupus erythematosus. Response to '2019 update of the EULAR recommendations for the management of SLE: don't forget chloroquine' by Figueroa-Parra et al. Annals of the rheumatic diseases 79 (9) (2019)
Efrosini Papadaki, E Kavroulakis, George K Bertsias, A Fanouriakis, D Karageorgou, P Sidiropoulos, E Papastefanakis, D T Boumpas, P Simos
Regional cerebral perfusion correlates with anxiety in neuropsychiatric SLE: evidence for a mechanism distinct from depression. Lupus 28 (14) (2019)
Nikolaos I Panousis, George K Bertsias, Halit Ongen, Irini Gergianaki, Maria G G Tektonidou, Maria Trachana, Luciana Romano-Palumbo, Deborah Bielser, Cedric Howald, Cristina Pamfil, Antonis Fanouriakis, Despoina Kosmara, Argyro Repa, Prodromos Sidiropoulos, Emmanouil T Dermitzakis, Dimitrios T Boumpas
Combined genetic and transcriptome analysis of patients with SLE: distinct, targetable signatures for susceptibility and severity. Annals of the rheumatic diseases 78 (8) (2019)
I Gergianaki, A Fanouriakis, C Adamichou, G Spyrou, N Mihalopoulos, S Kazadzis, L Chatzi, P Sidiropoulos, D T Boumpas, George K Bertsias
Is systemic lupus erythematosus different in urban versus rural living environment? Data from the Cretan Lupus Epidemiology and Surveillance Registry. Lupus 28 (1) (2018)
E A A Christou, A Banos, D Kosmara, George K Bertsias, D T Boumpas
Sexual dimorphism in SLE: above and beyond sex hormones. Lupus 28 (1) (2018)